Saccharomyces cerevisiae, known as baker's yeast, is normally considered a non-
pathogenic yeast. A genetically very similar subtype, S boulardii, is used in a probioticum …

Orally ingested probiotic micro-organisms do not exert health effects exclusively in the
intestine. Some strains can alleviate or prevent bacterial, fungal or viral infections in other …

Aims: This study was undertaken to characterize and differentiate therapeutically relevant
Saccharomyces yeasts. Among the isolates were so‐called Saccharomyces boulardii …

We previously found that Wickerhamomyces anomalus (formerly Hansenula anomala,
Pichia anomala) was the second most frequently isolated yeast in Belgian artisan bakery …

The yeast Saccharomyces boulardii is a biotherapeutic agent used for the prevention and
treatment of several gastrointestinal diseases, such as diarrhoea caused by Clostridium …

Saccharomyces cerevisiae, bakers' yeast, is not a pathogen in healthy individuals, but is
increasingly isolated from immunocompromised patients. The more frequent isolation of S …

Background In recent years there have been considerable interests in the use of probiotic
live cells for nutritional and therapeutic purposes. This strategy can be concomitant with …

Genetically identical cells exhibit extensive phenotypic variation even under constant and
benign conditions. This so-called nongenetic heterogeneity has important clinical …

Context Crohn's disease and ulcerative colitis result in similar gastrointestinal (GI)
symptoms, including pain, diarrhea, stools with mucus or blood, and ulceration or tissue …

Considering the clinical trial evidence of therapeutic benefit, probiotics are an underused
treatment modality for prevention and amelioration of diarrhoeal illness. Better …